Half of 'Micrococcus spp.' cases identified by conventional methods are revealed as other life-threatening bacteria with different drug susceptibility patterns by 16S ribosomal RNA gene sequencing. Issue 3 (March 2020)

• Record Type: Journal Article
• Authors: Noguchi, Kazuhiro; Nishimura, Ryosei; Ikawa, Yasuhiro; Mase, Shintaro; Matsuda, Yusuke; Fujiki, Toshihiro; Kuroda, Rie; Araki, Raita; Maeba, Hideaki; Yachie, Akihiro
• Is Part Of: Journal of infection and chemotherapy. Volume 26:Issue 3(2020:Mar.)
• Page Start: 318
• Page End: 319
• Publication Date: 2020-03
• Subjects: 16S rRNA gene sequence analysis -- Micrococcus -- Bacterial infection -- Kytococcus schroeteri -- Kocuria marina; ALL acute lymphoblastic leukemia -- RMS rhabdomyosarcoma -- AML acute myeloid leukemia; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2019.10.019
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Bacterial infection during chemotherapy is a fatal complication, therefore precise identification of the pathogenic microorganism is required for treatment. We report that 2 of 4 pediatric patients with malignancy who were diagnosed with Micrococcus spp. infection by conventional methods were finally revealed to have Kytococcus schroeteri and Kocuria marina infection by 16S ribosomal RNA gene sequence analysis (16S rRNA analysis). Although K. schroeteri is morphologically similar to Micrococcus spp., its drug susceptibility profile is quite different from that of Micrococcus spp. K. schroeteri is resistant to penicillin and cephalosporin, which are effective for Micrococcus spp. In fact, penicillin-resistant lethal pneumonia caused by K. schroeteri has been reported in compromised hosts. Based on our results, Micrococcus spp. determined by conventional methods could contain other life-threatening bacteria with different drug susceptibility patterns from Micrococcus spp. To develop an effective empirical treatment for immunocompromised hosts, accumulation of pathogen data by 16S rRNA analysis is required.